Table 2.
Parasitological data at enrolment
N | N (%) a | p/μL, (IQR) b | N (%) c | p/μL, (IQR) d | |
---|---|---|---|---|---|
Overall |
265 |
176/265 (66.4) |
3328 (940,12260) |
46/265 (17.4) |
94.1 (40,120) |
AL |
133 |
92/133 (69.2) |
4016.0 (1180,1500) |
31/133 (23.3) |
102.0 (40,120) |
Placebo |
132 |
84/132 (64.0) |
2710.3 (860,10660) |
15/132 (11.4) |
80.0 (40,120) |
Bed net users |
86 |
50/86 (58.1) |
2916.0 (880,10440) |
20/86 (23.3) |
112.0 (40,140) |
Bed net non users |
179 |
126/179 (70.4) |
3509.0 (960,13080) |
26/179 (15.0) |
83.0 (40,120) |
Age 12–23 mo |
89 |
46/89 (52.0) |
3296.0 (840,14560) |
14/89 (16) |
100.0 (40,120) |
Age 24–35 mo |
88 |
63/88 (72.0) |
3067.0 (720,10480) |
17/88 (19.3) |
101.0 (40,120) |
Age 36–47 mo |
88 |
67/88 (76.1) |
3620.3 (1440,12480) |
15/88 (17.1) |
75.2 (40,120) |
Anemic |
60 |
42/60 (70) |
4373.3 (1760,13360) |
8/60 (13.3) |
115.4 (40,100) |
Not anemic | 194 | 128/194 (66.0) | 3117.0 (780,12720) | 37/194 (19.1) | 92.2 (40,120) |
aAsexual parasite prevalence.
bAsexual parasite density (p/μL), Geometric mean (Inter Quartile Range [IQR]).
cGametocyte prevalence N (%).
dGametocyte density (p/μL), Geometric mean (Inter Quartile Range [IQR]).